Holen Sie sich die Stockscreener-App
76.84
3.76%
-3.00
Vorhandelsmarkt:
76.84
Schlusskurs vom Vortag:
$79.84
Offen:
$79.97
24-Stunden-Volumen:
431.15K
Relative Volume:
2.67
Marktkapitalisierung:
$849.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+9.10%
1M Leistung:
+16.81%
6M Leistung:
+214.15%
1J Leistung:
+0.00%
1-Tages-Spanne:
$72.18
$83.00
1-Wochen-Bereich:
$68.96
$83.00
52-Wochen-Spanne:
$11.17
$83.00
Palvella Therapeutics Inc Stock (PVLA) Company Profile
Firmenname
Palvella Therapeutics Inc
Sektor
Branche
Telefon
(484) 253-1461
Adresse
125 STRAFFORD AVE, WAYNE
Vergleichen Sie PVLA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PVLA
Palvella Therapeutics Inc
|
76.84 | 883.00M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Palvella Therapeutics Inc Stock (PVLA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-09 | Eingeleitet | Oppenheimer | Outperform |
| 2025-08-06 | Eingeleitet | Raymond James | Outperform |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-04-09 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-26 | Eingeleitet | Stifel | Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-02-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-02-05 | Eingeleitet | TD Cowen | Buy |
| 2024-12-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-03-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-07-30 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-05-14 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-03-19 | Eingeleitet | Evercore ISI | Outperform |
| 2018-03-19 | Eingeleitet | Jefferies | Buy |
| 2018-01-16 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-30 | Eingeleitet | Rodman & Renshaw | Buy |
| 2016-08-05 | Fortgesetzt | ROTH Capital | Buy |
| 2015-08-12 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-07-27 | Eingeleitet | Oppenheimer | Outperform |
| 2015-07-22 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Palvella Therapeutics Inc Aktie (PVLA) Neueste Nachrichten
Palvella Therapeutics to Host Third Quarter 2025 Financial - GlobeNewswire
Why Palvella Therapeutics Inc. stock remains a top recommendationEarnings Trend Report & Real-Time Buy Signal Alerts - newser.com
Can Palvella Therapeutics Inc. stock rebound after recent weaknessEarnings Summary Report & High Accuracy Trade Signal Alerts - newser.com
Can momentum traders help lift Palvella Therapeutics Inc.July 2025 Pullbacks & Verified Chart Pattern Signals - newser.com
Can Palvella Therapeutics Inc. stock sustain market leadership2025 Market Trends & High Accuracy Buy Signal Tips - newser.com
Trend analysis for Palvella Therapeutics Inc. this week2025 Biggest Moves & Short-Term Trading Alerts - newser.com
How Palvella Therapeutics Inc. stock performs in stagflationQuarterly Performance Summary & Expert Curated Trade Ideas - newser.com
What MACD and RSI say about Palvella Therapeutics Inc.Weekly Profit Summary & AI Optimized Trade Strategies - newser.com
Short interest data insights for Palvella Therapeutics Inc.Portfolio Risk Summary & Verified Short-Term Trading Plans - newser.com
Tools to monitor Palvella Therapeutics Inc. recovery probabilityJuly 2025 Technicals & Fast Exit Strategy with Risk Control - newser.com
Will Palvella Therapeutics Inc. stock go up soonProduct Launch & Technical Buy Zone Confirmation - newser.com
How Palvella Therapeutics Inc. (PI6) stock compares with top peersWeekly Stock Recap & Low Drawdown Momentum Ideas - newser.com
Will a bounce in Palvella Therapeutics Inc. offer an exitJuly 2025 Rallies & Safe Capital Allocation Plans - newser.com
How institutional ownership impacts Palvella Therapeutics Inc. stockJuly 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com
Can Palvella Therapeutics Inc. stock maintain growth trajectoryBear Alert & Momentum Based Trading Ideas - newser.com
Is Palvella Therapeutics Inc. (PI6) stock a good hedge against inflationJuly 2025 Trends & Precise Trade Entry Recommendations - newser.com
Why Palvella Therapeutics Inc. (PI6) stock is favored by hedge fundsWeekly Stock Recap & Weekly High Conviction Trade Ideas - newser.com
Forecasting Palvella Therapeutics Inc. price range with options dataMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
Can Palvella Therapeutics Inc. stock withstand economic slowdown2025 Top Gainers & Free High Return Stock Watch Alerts - newser.com
Can Palvella Therapeutics Inc. stock deliver consistent earnings growth2025 Investor Takeaways & Target Return Focused Picks - newser.com
Real time social sentiment graph for Palvella Therapeutics Inc.Earnings Miss & Stock Portfolio Risk Management - newser.com
Palvella Therapeutics (NASDAQ:PVLA) Hits New 52-Week HighWhat's Next? - MarketBeat
Why Palvella Therapeutics Inc. (PI6) stock is upgraded to buyInsider Buying & AI Enhanced Trade Execution Alerts - newser.com
How strong is Palvella Therapeutics Inc. stock balance sheet2025 Institutional Moves & Short-Term Trading Alerts - newser.com
Multi factor analysis applied to Palvella Therapeutics Inc.Earnings Miss & AI Driven Stock Price Forecasts - newser.com
Finanzdaten der Palvella Therapeutics Inc-Aktie (PVLA)
Es liegen keine Finanzdaten für Palvella Therapeutics Inc (PVLA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):